Acumen Pharmaceuticals (ABOS) Change in Acquisitions & Divestments (2022 - 2026)

Acumen Pharmaceuticals has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $27.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 57.67% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.3 million (down 45.12% YoY) and the FY2025 annual result came in at $172.1 million, down 21.34% from the prior year.
• Change in Acquisitions & Divestments advanced to $27.0 million in Q1 2026 per ABOS's latest filing, from $26.2 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $88.4 million in Q3 2024 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $34.0 million and a median of $34.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments soared 347.44% in 2024, then tumbled 57.67% in 2026.
• Over 5 years, Change in Acquisitions & Divestments stood at $9.0 million in 2022, then surged by 155.38% to $23.0 million in 2023, then soared by 94.76% to $44.8 million in 2024, then tumbled by 41.36% to $26.2 million in 2025, then increased by 2.92% to $27.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $27.0 million, $26.2 million, and $40.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.